3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Burkitt Lymphoma
23
Multiple Myeloma
21
Lymphoma, Large B-Cell, Diffuse
21
Leukemia, Myeloid, Acute
18
Lymphoma, Non-Hodgkin
16
Myelodysplastic Syndromes
15
Lymphoma, B-Cell
14
Lymphoma
14
Recurrence
11
Ovarian Neoplasms
11
Lymphoma, Follicular
11
Hodgkin Disease
11
Triple Negative Breast Neoplasms
10
Neoplasms
9
Lymphoma, Mantle-Cell
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Pancreatic Neoplasms
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia
8
Hematologic Neoplasms
7
Sarcoma
6
Osteosarcoma
6
Leukemia, Myelomonocytic, Chronic
6
Colorectal Neoplasms
6
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Biphenotypic, Acute
5
Graft vs Host Disease
5
Interventions
Specimen Handling
3
Nivolumab
3
Ipilimumab
3
cabozantinib
2
Magnetic Resonance Spectroscopy
2
CTLA-4 Antigen
2
Pluvicto
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Clear-cell metastatic renal cell carcinoma
×
Cyclophosphamide
×
30 days
×
Clear all
No trials found.